Study of naldemedine for opioid-induced constipation in cancer patients
Part of Cancer, Mental health clinical trials.
This trial tests whether naldemedine, a medication for constipation, can help cancer patients who have constipation caused by opioids. It looks at how well it works and how patients feel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with cancer
- You take opioids (pain medicine) every day
- You are currently using laxatives (medication for constipation)
- You are having constipation that bothers you
- You can fill out a questionnaire in Dutch
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether naldemedine is safe and how the body processes it in children who take opioid medicines and are dealing with constipation or are at risk for it. It may help some children by reducing constipation side effects from opioid pain treatment.
This study tests whether starting a bowel-prevention approach can help stop constipation caused by opioid pain medicines in people with advanced (metastatic) cancer. You may be able to join if you are about to start long-acting or skin opioid pain treatment.
This study looks at how well naldemedine (and certain other constipation medicines) lower the risk of major heart problems in people who take opioids for constipation. It compares medicine use patterns in people with opioid-induced constipation to see who has fewer serious heart events.
This trial tests a sustained-release tablet (oxycodone/naloxone) for cancer patients with severe pain and constipation caused by opioids. It aims to see how well the drug works in real-world conditions.
This study tests a traditional Chinese medicine treatment for constipation caused by opioid pain medications in cancer patients. The goal is to help people on long-term opioid therapy have more regular bowel movements without increasing laxative use.
This study tests whether the combination of olanzapine and metoclopramide can prevent nausea and vomiting caused by strong painkillers (opioids) in people with advanced cancer. If you are starting a strong opioid for pain and have not had nausea or vomiting recently, this study may be for you.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.